Apple Watch Series 9 and Watch Ultra 2 Users in the US Face Delay in Blood Oxygen Monitoring Feature Restoration

Wednesday, 13 March 2024, 08:24

US users of Apple Watch Series 9 and Watch Ultra 2 may experience a delay until 2028 to regain access to the blood oxygen monitoring feature due to patent infringement issues with Masimo. The feature was disabled in January after Apple was found to infringe on Masimo's patents.
https://store.livarava.com/cd7f34c2-e18f-11ee-966b-5254a2021b2b.png
Apple Watch Series 9 and Watch Ultra 2 Users in the US Face Delay in Blood Oxygen Monitoring Feature Restoration

Apple Watch Blood Oxygen Monitoring Feature Delayed

Apple Watch Series 9 and Watch Ultra 2 users in the United States may have to wait until 2028 to regain access to the blood oxygen monitoring feature. In January earlier this year, Apple was forced to disable pulse oximetry in these models sold in the US after being found to infringe on patents owned by Masimo, a medical technology company.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe